Personalized vaccines for cancer immunotherapy
Top Cited Papers
- 23 March 2018
- journal article
- review article
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 359 (6382), 1355-1360
- https://doi.org/10.1126/science.aar7112
Abstract
Cancer is characterized by an accumulation of genetic alterations. Somatic mutations can generate cancer-specific neoepitopes that are recognized by autologous T cells as foreign and constitute ideal cancer vaccine targets. Every tumor has its own unique composition of mutations, with only a small fraction shared between patients. Technological advances in genomics, data science, and cancer immunotherapy now enable the rapid mapping of the mutations within a genome, rational selection of vaccine targets, and on-demand production of a therapy customized to a patient’s individual tumor. First-in-human clinical trials of personalized cancer vaccines have shown the feasibility, safety, and immunotherapeutic activity of targeting individual tumor mutation signatures. With vaccination development being promoted by emerging innovations of the digital age, vaccinating a patient with individual tumor mutations may become the first truly personalized treatment for cancer.Keywords
This publication has 47 references indexed in Scilit:
- Tumor Exome Analysis Reveals Neoantigen-Specific T-Cell Reactivity in an Ipilimumab-Responsive MelanomaJournal of Clinical Oncology, 2013
- Mining exomic sequencing data to identify mutated antigens recognized by adoptively transferred tumor-reactive T cellsNature Medicine, 2013
- Exploiting the Mutanome for Tumor VaccinationCancer Research, 2012
- Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoeditingNature, 2012
- CD8+ T Cells: Foot Soldiers of the Immune SystemImmunity, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- DNA vaccines: precision tools for activating effective immunity against cancerNature Reviews Cancer, 2008
- CD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytesNature, 2003
- A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human MelanomaScience, 1991
- Lack of HLA class I antigen expression by cultured melanoma cells FO-1 due to a defect in B2m gene expression.JCI Insight, 1991